Revolution Medicines Inc (RVMD)

Date: O: H: L: C: Vol:

Finanzdaten der Revolution Medicines Inc-Aktie (RVMD)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	13.46%505.13	445.22	361.63	315.27	264.71
Research and Development	14.81%394.92	343.97	294.94	262.51	224.13
Operating Income/Loss	13.46%-505.13	-445.22	-361.63	-315.27	-264.71
Nonoperating Income/Loss	1,520%-139.24	-8.59	-3.27	10.06	16.93
Income/Loss From Continuing Operations Before Tax	41.99%-644.37	-453.82	-364.89	-305.21	-247.79
	41.99%-644.37	-453.82	-364.89	-305.21	-247.79
Attributable To Parent	41.99%-644.37	-453.82	-364.89	-305.21	-247.79
Available To Common Stockholders, Basic	41.99%-644.37	-453.82	-364.89	-305.21	-247.79
Basic Average Shares	6.46%210.89	198.10	1.47	189.23	188.58
Diluted Average Shares	6.46%210.89	198.10	1.47	189.23	188.58
Basic Earnings Per Share	33.62%-3.06	-2.29	-1.89	-1.61	-1.31
Diluted Earnings Per Share	33.62%-3.06	-2.29	-1.89	-1.61	-1.31